Clinical Trial Update: Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of Alirocumab on lipid metabolism in adults with elevated LDL-cholesterol has completed. The study assessed changes in lipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Praluent (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED